Across the world infectious disease cases are rising, fueling demand for technologies that can detect them. This report, Infectious Disease Molecular Diagnostics Market, contains market sizing and forecasts for several segments of infectious disease testing:
- Infectious Disease Market, 2016-2021
- HPV Diagnostics Market, 2016 to 2021
- RSV Diagnostics Market, 2016 to 2021
- Mycobacteria/TB Molecular Diagnostics Market, 2016 to 2021
- Other Infectious Disease Molecular Diagnostics Market, 2016 to 2021
- Overall Molecular Diagnostic Market, 2016 to 2021
- Trends in the Market
- Market Share for Infectious Disease Molecular Testing Market
- NAT Blood Screening Market 2016-2012
- Hepatitis Test Market
- HIV Diagnostics Market, 2016 to 2021
- HAIs/Sepsis Diagnostics Market, 2016 to 2021
- CT/NG Diagnostics Market, 2016 to 2021
The report also contains company profiles and detailed product tables and important market trends.
This Kalorama Information report provides market sizes and forecasts for this important category of molecular testing. Infectious disease is projected to account for 60% of the global molecular diagnostics market by 2021 or roughly $5.9 billion in sales. The market segment is defined by test decentralization with the introduction of NAAT platforms able to be operated in hospital labs and near-patient points of care such as physician office labs (POLs) and outpatient clinics. Integrated design from sample preparation to results analysis and user friendly features are just as appealing to larger clinical labs to free up personnel. Menu expansion on integrated analyzers has been the predominant focus of competitors in molecular infectious disease diagnostics. Market share and client retention depend on the ability of one platform to perform all routine infectious disease tests.
ONE: EXECUTIVE SUMMARY
- Introduction
- Overall Molecular Diagnostics Market
- Molecular Diagnostic Technologies
- Molecular Diagnostics In Healthcare
- Global Molecular Diagnostics Market
- Table 1-1: Global Molecular Diagnostics Market (2016-2021) – Infectious Disease, Blood Screening, Histology, Cancer Assays, Transplant, Inherited Diseases ($ Millions)
- Figure 1-1: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
- Conclusions
- Introduction
- Nucleic Acid Amplification Test (NAAT) Technologies
- Real-Time Pcr (Qpcr)
- Isothermal Amplification
- Table 2-1: Selected Isothermal Amplification Methods And Platform Examples
- Trends In Nucleic Acid Amplification Testing And Emerging Technologies
- Microarrays
- Table 2-2: Selected Clinical Array Component And Microarray Systems
- Introduction
- Reimbursement Environment for Molecular Diagnostics
- Molecular Diagnostics And The Clinical Utility Standard
- Laboratory-Developed Tests Are Here To Stay Conclusions
- Market Size and Forecast by Category
- Table 4-1: Market-Available Molecular Diagnostic Platforms - POC, Hospital And Developing World (Vendor, Assay Menu, Planned Assays, Regulatory Status, Procedure Integration, Test PrincipleMarket Analysis
- Table 4-2: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ Millions)
- Figure 4-1 Global Molecular Infectious Disease Diagnostics Market (2016) - Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ Millions)
- Figure 4-2 Global Molecular Infectious Disease Diagnostics Market (2016-2021) – Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ Millions)
- Table 4-3: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
- Figure 4-3: Global Molecular Infectious Disease Diagnostics Market (2016) - United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
- Figure 4-4: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
- Figure 4-5: Global Molecular Infectious Disease Diagnostics Market Share - Abbott Diagnostics, BD, Biomérieux, Cepheid, Hologic, Qiagen, Roche Diagnostics, Siemens Healthcare Diagnostics, Others (%)
- CT/NG, HPV And Women’s Health
- Hepatitis
- HIV
- Hospital-Acquired Infections (HAIs) And Sepsis
- Respiratory
- Tuberculosis
- Market for Molecular Blood Transfusion Diagnostics
- Introduction
- Market Analysis
- Table 4-4: Global NAT Blood Screening (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
- Figure 4-6: Global NAT Blood Screening Market (2016) - United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
- Figure 4-7 Global NAT Blood Screening Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
- Table 4-5: Commonly Tested Pathogens In Blood Screening
- Figure 4-8: Global NAT Blood Screening Share - Grifols, Roche Diagnostics, Others (%)
- New Infectious Disease Threats And Assay Introduction
- Conclusions
Abbott Diagnostics
- Table 5-1: Abbott Diagnostics Revenue (2013-2016) ($ Millions)
- Infectious Diseases/qPCR
- Cytogenetics/Oncology/FISH
- Molecular ID/AST
- Table 5-2: Agilent Technologies Revenue (Fy 2013-Fy 2016) ($ Millions)
- Alere
- Table 5-3: Alere Revenue (2013- 2016) ($ Millions)
Beckman Coulter (Danaher)
Becton, Dickinson & Co. (BD)
- Table 5-4: Becton, Dickinson & Co. (BD) Revenue (Fy 2013-Fy 2016) ($ Millions)
- Molecular
- Histology/Cytology
- Flow Cytometry
- Table 5-5: Biomérieux Revenue (2013-2016) ($ Millions)
- Molecular
- Sequencing
- Transplant Diagnostics
- Molecular Diagnostic Qc Products
- Sequencing
- Table 5-6: Cepheid Revenue (2013-2016) ($ Millions)
- Molecular Hospital-Acquired Infection (HAI) Testing
- Molecular Sexual Health And Women’s Health Testing
- Molecular Critical Infectious Disease Testing
- Molecular Oncology Testing
Eiken Chemical
- Table 5-7: Eiken Chemical Revenue (Fy 2013-Fy 2016) ($ Millions)
- Table 5-8: Grifols Diagnostic Revenue (2013-2016) ($ Millions)
- Molecular Immunohematology And Specialty Testing Services
- NAT Blood Screening
- Table 5-9: Hologic Revenue (Fy 2013-Fy 2016) ($ Millions)
- Molecular Cytology / Histology (HPV)
- Other Molecular (Stis, HIV, Hcv, TB, Respiratory)
- Microbiology (Accuprobe Molecular Culture Id Tests)
- Table 5-10: Illumina Revenue (2013-2016) ($ Millions)
- Sequencing
- Translational Research
- Clinical Assay Development
- Industry Lab-Developed Tests
- Arrays
- Table 5-11:Immucor Revenue (Fy 2013-Fy 2016) ($ Millions)
- Transfusion Diagnostics
- Transplant Diagnostics
- Immucor Dx Laboratory Service
- Janssen Diagnostics (Johnson & Johnson)
- Table 5-13: Luminex Corporation Revenue (2013- 2016) ($ Millions)
- Business Expansion
- Magpix Multiplexing
- Aries Molecular System
- Table 5-14: Meridian Bioscience Revenue (Fy 2013-Fy 2016) ($ Millions)
- Table 5-15: Qiagen Revenue (2013-2016) ($ Millions)
- Molecular Infectious Disease
- Cancer Diagnostics
- Transplant Diagnostics
- Next-Generation Sequencing
- Circulating Tumor Cells
- Table 5-16: Quidel Revenue (2013-2016) ($ Millions)
- Table 5-17: Roche Diagnostics Revenue (2013-2016) ($ Millions)
- Molecular Diagnostics
- Blood Screening
- Sequencing
- Liquid Biopsy
- Microbiology
Thermo Fisher Scientific
- Table 5-18: Thermo Fisher Scientific Revenue (2013-2016) ($ Millions)
- Transplant Diagnostics
- PCR
- Sequencing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook